<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK Life Sciences News and Analysis Blog

2 min read

A Journey Back to Normalcy: Q320 Hemostats and Sealants Market Recap

12/7/20 9:58 AM

Q320 Hemostats and Sealants Market OverviewThe US market for Hemostats and Sealants began the journey back to normalcy, slipping -0.2% YoY in Q320, as elective surgeries began to be performed again. Hemostats led the charge with Sealants not far behind.

As the US healthcare system begins to manage COVID-19 and elective procedures return toward pre-COVID-19 levels, the US Hemostats and Sealants market rebounded with a drop of only -0.2% YoY in Q320 according to SmartTRAK Financial Dashboard. Most manufacturers still experienced declines in Q320, but far narrower than the losses of Q220. Ethicon* managed a +4.5% gain in Q320 while the other manufacturers essentially treaded water with respect to Q319.

Among the many topics covered in the comprehensive Q320 US Hemostats and Sealants Market Recap* are:

  • Complete US Hemostats & Sealants Market Overview
  • Companies' Revenue and Market Shares
  • Biosurgery Market Regains Its Footing
  • Absorbable Hemostats Lead The Charge Back
  • Fibrin Sealants Lead The Recovery
  • Q320 Regulatory Events and Clinical Trials

As before the COVID-19 downturn, Ethicon continued to lead the overall US Hemostat and Sealants market in Q320 and managed to post a gain of +4.3% YoY to $XXX Blurred PERCENTAGE V2-1MM* in revenue and 42.7% market share, in large part due to its widespread presence in hospitals where it could take advantage faster of the recovery in procedures. A recovering Baxter nonetheless fell behind Ethicon, while Becton Dickinson* (BD) in third place gained slightly on Baxter, posting revenue of ...

Read the entire Q320 US Hemostats and Sealants  Market Recap including news, data, charts, company revenues, shares and analysis*

*The entire article and the links can only be viewed by SmartTRAK subscribers to this module. For more information on how to receive a demo and subscribe, please click the button below.

Learn More


SmartTRAK is a comprehensive, easy-to-use, business intelligence solution that networks an entire organization with real-time market data and analysis. Used by the 15 top Advanced Wound Care companies and 8 of the 10 top Orthopedic companies, SmartTRAK transforms the delivery of healthcare business information into a cost-effective solution for life science corporations to increase proficiency, improve productivity and reduce cost.

Topics: Wound Care

Doug Devens
Written by Doug Devens

20 years of diverse medical device experience, including leading companies 3M, Coloplast and Boston Scientific, along with emerging companies. Leadership experience in product development, including championing the process for voice of customer and concept feedback sessions with key thought leaders.

    Follow Us on Social Media

    Recent Articles